126 related articles for article (PubMed ID: 38040536)
41. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
[TBL] [Abstract][Full Text] [Related]
42. [Surgical treatment of metastases in renal cell carcinoma].
Langer W; Hofmockel G; Theiss M; Frohmüller H
Urologe A; 1997 Nov; 36(6):548-51. PubMed ID: 9487591
[TBL] [Abstract][Full Text] [Related]
43. Renal cell carcinoma: analysis of postoperative recurrence patterns.
Chae EJ; Kim JK; Kim SH; Bae SJ; Cho KS
Radiology; 2005 Jan; 234(1):189-96. PubMed ID: 15537838
[TBL] [Abstract][Full Text] [Related]
44. Imaging strategy and outcome following partial nephrectomy.
Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
[TBL] [Abstract][Full Text] [Related]
45. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma.
Song W; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
World J Urol; 2016 Jan; 34(1):83-8. PubMed ID: 25981404
[TBL] [Abstract][Full Text] [Related]
46. Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.
Kim EH; Vetter JM; Kuxhausen AN; Song JB; Sandhu GS; Strope SA
Urol Oncol; 2016 May; 34(5):237.e11-8. PubMed ID: 26725251
[TBL] [Abstract][Full Text] [Related]
47. Is there a need for pelvic CT scan in cases of renal cell carcinoma?
Khaitan A; Gupta NP; Hemal AK; Dogra PN; Seth A; Aron M
Int Urol Nephrol; 2002; 33(1):13-5. PubMed ID: 12090319
[TBL] [Abstract][Full Text] [Related]
48. Clinical usefulness of chest radiography in detection of pulmonary metastases after curative resection for colorectal cancer.
Lee WS; Yun SH; Chun HK; Lee WY; Yun H
World J Surg; 2007 Jul; 31(7):1502-6. PubMed ID: 17483984
[TBL] [Abstract][Full Text] [Related]
49. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas.
Fleming JB; Cantor SB; Varma DG; Holst D; Feig BW; Hunt KK; Patel SR; Benjamin RS; Pollock RE; Pisters PW
Cancer; 2001 Aug; 92(4):863-8. PubMed ID: 11550159
[TBL] [Abstract][Full Text] [Related]
50. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
51. Oncologic outcome of 132 cases of laparoscopic radical nephrectomy with intact specimen removal for T1-2N0M0 renal cell carcinoma.
Hemal AK; Kumar A; Gupta NP; Kumar R
World J Urol; 2007 Dec; 25(6):619-26. PubMed ID: 17786453
[TBL] [Abstract][Full Text] [Related]
52. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
53. Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial.
Narayan V; Puligandla M; Haas NB; Subramanian P; DiPaola RS; Uzzo R
J Urol; 2019 Jan; 201(1):62-68. PubMed ID: 30130544
[TBL] [Abstract][Full Text] [Related]
54. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
55. ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update.
; Purysko AS; Nikolaidis P; Khatri G; Auron M; De Leon AD; Ganeshan D; Gore JL; Gupta RT; Shek-Man Lo S; Lyshchik A; Savage SJ; Smith AD; Taffel MT; Yoo DC; Lockhart ME
J Am Coll Radiol; 2022 May; 19(5S):S156-S174. PubMed ID: 35550799
[TBL] [Abstract][Full Text] [Related]
56. [Partial elective nephrectomy].
Zungri E; Martínez L; Leal D; Lorenzo L
Actas Urol Esp; 2012 Mar; 36(3):160-4. PubMed ID: 21955560
[TBL] [Abstract][Full Text] [Related]
57. Robotic excision of recurrent renal cell carcinomas with laparoscopic ultrasound assistance.
Gilbert D; Abaza R
Urology; 2015 May; 85(5):1206-1210. PubMed ID: 25917737
[TBL] [Abstract][Full Text] [Related]
58. Pulmonary metastasectomy from renal cell carcinoma including 3 cases with sarcomatoid component.
Ueno T; Yamashita M; Sawada S; Sugimoto R; Nishijima N; Sugawara Y; Ninomiya I
Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):149-52. PubMed ID: 26809845
[TBL] [Abstract][Full Text] [Related]
59. [Outcomes of Surgical Cases of Solitary Rib Metastases in Renal Cell Carcinoma].
Aoshima H; Omata M; Shidei H; Ogihara A; Mithuboshi S; Matsumoto T; Isaka T; Kanzaki M
Kyobu Geka; 2022 Dec; 75(13):1071-1073. PubMed ID: 36539220
[TBL] [Abstract][Full Text] [Related]
60. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
